Inside Therapeutics
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Inside Therapeutics?
Inside Therapeutics is currently owned by Aquiti Gestion through AVA 1 (Aquiti Venture Amorcage) (2024 vintage), since 2024. Across its history, Inside Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Aquiti GestionAVA 1 (Aquiti Venture Amorcage) · 2024 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
Newfund ManagementActive
2024 · present(2yr) · Newfund HEKA · 2023 · VC
Aquiti GestionActive
2024 · present(2yr) · AVA 1 (Aquiti Venture Amorcage) · 2024 · VC
More from AVA 1 (Aquiti Venture Amorcage)
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Inside Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Inside Therapeutics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Inside Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue